Yourgene Health has launched the Yourgene Insight DPYD assay, expanding detection to 19 variants for DPD deficiency screening in cancer patients receiving 5-fluorouracil, with same-day results and initial Research Use Only availability.
The collaboration combines Profluent’s generative AI platform with IDT’s enzyme engineering and genomics expertise to accelerate development of next-generation enzymes.
Researchers have developed a CRISPR-Cas10-integrated graphene biosensor for amplification-free, ultra-sensitive RNA and miRNA detection.
Research shows that cell-free DNA in cerebrospinal fluid can be used to identify patients at risk of pediatric medulloblastoma relapse.
Read More
CRISPR technology may transform diagnostic capabilities by providing the sensitivity and flexibility of PCR tests but with increased speed and lower cost.
Read More
A researcher is using nanodisks to provide a way to rapidly and efficiently identify and monitor small cancer cells.
Read More
Technology developed by scientists at Lawrence Berkeley National Laboratory shows promise for diagnosing Alzheimer’s disease before symptoms arise.
Read More
PCR Biosystems’ new range of IsoFast Bst reagents can be used for a variety of techniques including whole genome amplification, multiple displacement amplification, and isothermal amplification.
Read More
The Crescendo cDNA Synthesis for qPCR system can generate large quantities of cDNA from as little as 500 pg of total RNA.
Read More
The Chromatrap Homogeniser Spin Column has been adapted to routinely improve yield and quality of covid-19 viral RNA from nasal and throat swab samples.
Read More